USRMOTCHealthcare · Biotechnology

U.S. Stem Cell, Inc.

$0.00+0.00%(+$0.00)

TickerSpark Score

52/100

Mixed

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a USRM research report →

52-Week Range0% of range

Low $0.00

Current $0.00

High $0.00

Companywww.us-stemcell.com

U. S. Stem Cell, Inc.

CEO: Michael Tomas
IPO: 2008
Employees: 11
HQ: Sunrise, FL, US

Price Chart

-0.00% · this period

Valuation

Market Cap: $64.15K
P/E: -0.02
P/S: 0.78
P/B: -0.00
EV/EBITDA: -4.15
Div Yield: 0.00%

Profitability

Gross Margin: 71.03%
Op Margin: -2096.90%
Net Margin: -3483.21%
ROE: 20.78%
ROIC: 29.95%

Growth & Income

Revenue: $82.05K · -59.13%
Net Income: $-2,857,943 · 13.06%
EPS: $-0.00 · 32.39%
Op Income: $-1,720,484
FCF YoY: 71.18%

Performance & Tape

52W High: $0.00
52W Low: $0.00
50D MA: $0.00
200D MA: $0.00
Beta: -48.37
Avg Volume: 50.45K

Get TickerSpark's AI analysis on USRM

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

Date	Insider	Role	Type	Shares	Value
Apr 25, 22	Knutson Gregory	director:	other	2,500,000	$10.00K
Mar 18, 22	Knutson Gregory	director:	other	25,000,000	$200.00K
Feb 24, 22	Knutson Gregory	director	other	12,500,000	$100.00K
Feb 24, 22	Knutson Gregory	director	other	12,500,000	$100.00K
Mar 23, 21	MURPHY WILLIAM P JR	director	other	7,518,797	$200.00K
Apr 2, 21	Knutson Gregory	director	other	187,575	$9.13K
Oct 5, 20	Knutson Gregory	director	other	2,035,820	$9.16K
Apr 1, 20	Knutson Gregory	director	other	1,445,647	$8.67K
Feb 17, 21	Knutson Gregory	director	other	3,759,398	$100.00K
Nov 18, 19	TOMAS MIKE	director, officer: President & CEO	other	1,500,000	$7.35K